About Vantage

 

VANTAGE ONCOLOGY CHIEF TECHNOLOGY OFFICER AWARDED ASTRO 2008 GOLD MEDAL

Christopher Rose, M.D., Honored by ASTRO for Outstanding Leadership and Clinical Achievement in the Field of Radiology

June 4, 2008

Christopher Rose, M.D., FASTRO addresses audience, accepts award

MANHATTAN BEACH, CA – Vantage Oncology, Inc., a Manhattan Beach, Calif.-based developer and operator of state-of-the-art radiation oncology centers, has announced that Christopher Rose, M.D., FASTRO, the company’s Chief Technology Officer, was selected by The American Society for Therapeutic Radiology (ASTRO) as a recipient of the 2008 Gold Medal. It is the highest honor that ASTRO bestows.

Christopher Rose, M.D., FASTRO, and Joel Tepper, M.D., FASTRO, will be presented with their awards during ASTRO’s 50th Annual Meeting in Boston during the Gold Medal Ceremony held on Tuesday, September 23, at 10:00 a.m.

“It seems particularly fitting that we recognize these two leaders in the field of radiation oncology and former leaders of ASTRO as part of our 50th anniversary celebration,” said Louis Harrison, M.D., chairman of ASTRO’s Board of Directors and a radiation oncologist at Beth Israel Medical Center in New York City. “Both of these leaders have served as role models to me and I will take great personal pride in being able to present them with their medals.”

Dr. Rose is the Technical and Associate Director of Valley Radiotherapy Associates Medical Group, Medical Director of the Center for Radiation Therapy of Beverly Hills and Chief Technology Officer of Vantage Oncology, Inc. He graduated from Harvard Medical School in Boston and did both his Internship and Residency in Internal Medicine at Beth Israel Hospital in Boston. Dr. Rose also completed his Residency in Radiation Therapy at the Joint Center for Radiation Therapy in Boston and a Fellowship at the Royal Marsden Hospital in Sutton, UK. He has served in several academic appointments, including Instructor and Assistant Professor of Radiation Oncology at Harvard Medical School and Associate Clinical Professor of Radiation Oncology at the University of Southern California in Los Angeles.

“It is a tremendous honor for me to receive ASTRO’s Gold Medal, but it is even more gratifying to be recognized by my peers and colleagues,” explained Dr. Rose. “I credit my mentors and friends, Dr. Samuel Hellman and Dr. Leslie Botnick, for inspiring me to pursue this profession with the passion and dedication needed to improve cancer patients’ quality of life. I have always wanted a sense of ‘utility’ in my career. The ability to have a positive impact on people’s lives is an incredible gift that I have never taken for granted and it is the most rewarding aspect of what I do everyday.”  

Dr. Rose is a member of several professional societies, including the American Society of Clinical Oncology and the Radiation Research Society. He is Vice-Chair of the Quality Research in Radiation Oncology Grant of the American College of Radiology and Co-Chair of ASTRO’s Quality Steering Committee. He was named a Fellow of the American College of Radiology in 1993, a Fellow of ASTRO in 2006 and has served as President of the Southern California Radiation Oncology Society, CARROS and ASTRO.
“We are extremely excited and proud that Dr. Rose was selected as a recipient of this prestigious honor,” said Michael T. Fiore, CEO of Vantage Oncology, Inc. “Dr. Rose is an outstanding radiation oncologist and technical advisor for Vantage Oncology, but his compassion for patients and tireless dedication to his specialty is what sets him apart from his peers. It is an outstanding accomplishment for Dr. Rose and much deserved for the positive impact he has on his colleagues and patients.”

About ASTRO
ASTRO is the largest radiation oncology society in the world, with more than 9,000 members who specialize in treating patients with radiation therapies. As the leading organization in radiation oncology, biology and physics, the Society is dedicated to improving patient care through education, clinical practice, advancement of science and advocacy. 

About Vantage Oncology, Inc.
Founded in October 2002, Manhattan Beach, California-based Vantage Oncology, Inc., acquires, joint ventures, develops and operates state-of-the-art radiation oncology centers.  Vantage Oncology was created in response to the growing need among cancer patients, hospitals and physicians for accessible and advanced radiation treatment therapies.  Vantage Oncology is led by a seasoned management team, including Chief Executive Officer Michael Fiore, Medical Director Leslie Botnick, M.D., Chief Financial Officer Marshal Salomon and Chief Development Officer Mark Ahern.  For more information about Vantage Oncology, visit www.vantageoncology.com.

# # #

CONTACT:            

Trace Longo
Longo Communications
(949) 364-2821 

Vantage Oncology, Marketing Dept.
email:info@vantageoncology.com